SCLERO.ORG is retiring 4-24-2021. Thank you for the memories! You'll still find us in the Wayback Machine, and we'll carry your stories in our hearts forever.
Scleroderma Newsroom
ISN News Manager: Jo Frowde
Media Stories
Autoimmune Archive
We maintain news archives for the most recent 3 years.
2020: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2021 - 2020 - 2019 - 2018

July 2020 Autoimmune News

The Impact of Tocilizumab (TCZ) on Anxiety and Depression in Patients With Rheumatoid Arthritis (RA). This study has demonstrated a favourable impact of TCZ therapy on parameters reflecting depression and anxiety severity in patients with RA. PubMed, Eur J Clin Invest, 2020 Jun 1;e13268. (Also see Clinical Trials, Depression and Symptoms and Complications of Rheumatoid Arthritis)

Long-Term Safety of Rituximab in Granulomatosis With Polyangiitis (GPA) or Microscopic Polyangiitis (MPA). These findings provide clinicians with long-term, practice-level safety data for rituximab in the treatment of GPA or MPA. PubMed, Arthritis Care Res (Hoboken), 05/31/2020. (Also see Granulomatosis with Polyangiitis)

Comparison of Effect on Sicca Symptoms of Anticentromere Antibody-positive (ACA) Sjögren Syndrome (SS) and Primary Sjögren Syndrome (pSS) Alone. ACA+ SS is associated with more severe objective ocular sicca and more severe subjective and objective oral sicca compared to ACA-SS. PubMed, J Rheumatol, 2020 Jun 1;47(6):876-880. (Also see Diagnosis of Sjögren's Syndrome)

Comparative Persistence of Methotrexate (MTX) and Tumor Necrosis Factor Inhibitors (TNFi) in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis. Concomitant use of MTX with a TNFi, however, is associated with improved TNFi persistence in all 3 diseases. PubMed, J Rheumatol, 2020 Jun 1;47(6):826-834. (Also see Treatments for Rheumatoid Arthritis, Psoriasis and Psoriatic Arthritis, Ankylosing Spondylitis and Immunosuppressants)

Anti-citrullinated Protein Antibody (ACPA) Specificities, Rheumatoid Factor (RF) Isotypes and Incident Cardiovascular (CV) Events in Patients With Rheumatoid Arthritis. RF isotypes and ACPA are associated with future CV events. PubMed, Arthritis Rheumatol, 05/31/2020. (Also see Symptoms and Complications of Rheumatoid Arthritis)

Increased Cardiovascular (CVD) Risk and All-cause Death in Patients With Behçet Disease (BD): A Korean Nationwide Population-based Dynamic Cohort Study. Patients with BD must be carefully monitored for the potential development of CVD to ensure that appropriate early treatments are delivered. PubMed, J Rheumatol, 2020 Jun 1;47(6):903-908. (Also see Behçet's Disease)

Predictors of New Onsets of Irritable Bowel Syndrome (IBS), Chronic Fatigue Syndrome (CFS) and Fibromyalgia (FM): The Lifelines Study. The close relationship between IBS and FM is striking and requires further research. PubMed, Psychol Med, 2020 Jun 17;1-9. (Also see Fibromyalgia, Bowel Dysfunction and Chronic Fatigue Syndrome)

Non-bladder Centric Interstitial cystitis (IC)/bladder Pain Syndrome (BPS) Phenotype Is Significantly Associated With Co-Occurring Endometriosis. This study characterizes features of a target IC/BPS phenotype that could potentially benefit from endometriosis and systemic pain syndrome screening. PubMed, Can J Urol, 2020 Jun;27(3):10257-10262. (Also see Interstitial Cystitis and Autoimmune Disease Directory)

Sifting the Wheat From the Chaff? Evidence for the Existence of an Asymmetric Fibromyalgia Phenotype. Within the current FM criteria, there exist different phenotypes with clinical, psychophysics, and neurophysiological findings. PubMed, Eur J Pain, 06/13/2020. (Also see Fibromyalgia)

Rheumatoid Arthritis (RA): The Impact of Mental Health on Disease: A Narrative Review. It is important to determine the most appropriate tool to monitor mental health well-being and quality of life of RA patients in rheumatology outpatient clinics. PubMed, Rheumatol Ther, 06/13/2020. (Also see Symptoms and Complications of Rheumatoid Arthritis and Depression)

Go to Autoimmune News: June 2020

SCLERO.ORG is the world's leading nonprofit for trustworthy research, support, education and awareness for scleroderma and related illnesses. We are a 501(c)(3) U.S.-based public charitable foundation, established in 2002. Meet Our Team. Donations may also be mailed to:

International Scleroderma Network (ISN)
7455 France Ave So #266
Edina, MN 55435-4702 USA
Email [email protected]. Disclaimer. Privacy Policy.